Korea Arlico Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19,312	15,484	19,066	23,395	9,520
Short-Term Investments	97.42	652.72	6,164	6,512	13,612
Trading Asset Securities	1,584	3,057	5,560	2,296	5,616
Cash & Short-Term Investments	20,993	19,194	30,790	32,203	28,747
Cash Growth	9.37%	-37.66%	-4.39%	12.02%	47.30%
Accounts Receivable	27,693	30,073	22,362	19,886	19,304
Other Receivables	399.86	50.12	46.58	110.46	74.88
Receivables	28,093	30,123	22,409	19,997	19,379
Inventory	32,637	32,798	26,779	27,437	19,759
Prepaid Expenses	4.63	7.05	7.97	7.25	5.78
Other Current Assets	1,175	3,212	3,570	2,479	964.07
Total Current Assets	82,902	85,334	83,555	82,123	68,855
Property, Plant & Equipment	61,994	63,152	66,740	49,726	31,641
Long-Term Investments	8,196	8,730	10,137	9,313	12,168
Other Intangible Assets	8,632	7,148	7,013	6,958	3,967
Long-Term Accounts Receivable	-	-	-0	0	0
Long-Term Deferred Tax Assets	7,341	6,140	4,365	4,071	3,741
Other Long-Term Assets	1,778	859.02	1,666	1,344	688.89
Total Assets	171,844	172,363	173,477	153,536	121,062
Accounts Payable	6,271	7,325	4,851	4,806	5,111
Accrued Expenses	9,490	10,699	11,868	12,407	10,038
Short-Term Debt	41,104	41,537	39,330	25,064	10,262
Current Portion of Long-Term Debt	2,667	1,932	-	2,000	191.4
Current Portion of Leases	245.65	250.58	152.42	151.35	82.2
Current Income Taxes Payable	593.97	-	-	883.22	840.4
Current Unearned Revenue	-	-	-	2.46	-
Other Current Liabilities	13,595	13,452	14,119	11,944	7,244
Total Current Liabilities	73,966	75,195	70,320	57,258	33,770
Long-Term Debt	4,944	6,592	6,746	3,746	2,000
Long-Term Leases	83.56	145.65	61.2	135.05	65.21
Pension & Post-Retirement Benefits	785.44	610.34	-	-	727.58
Other Long-Term Liabilities	13,862	10,140	7,275	3,851	3,370
Total Liabilities	93,641	92,684	84,402	64,990	39,933
Common Stock	7,664	7,664	7,664	7,664	7,664
Additional Paid-In Capital	40,473	40,143	40,143	40,143	40,143
Retained Earnings	34,235	35,520	43,743	43,156	35,904
Treasury Stock	-3,082	-3,082	-3,082	-3,082	-3,082
Comprehensive Income & Other	-1,086	-565.06	608.09	665.54	501.14
Shareholders' Equity	78,203	79,679	89,075	88,546	81,129
Total Liabilities & Equity	171,844	172,363	173,477	153,536	121,062
Total Debt	49,044	50,457	46,289	31,096	12,601
Net Cash (Debt)	-28,051	-31,263	-15,499	1,107	16,146
Net Cash Growth	-	-	-	-93.14%	64.53%
Net Cash Per Share	-1853.57	-2082.99	-919.90	73.29	1071.03
Filing Date Shares Outstanding	15.49	15.01	15.01	15.01	15.01
Total Common Shares Outstanding	15.49	15.01	15.01	15.01	15.01
Working Capital	8,937	10,139	13,235	24,865	35,085
Book Value Per Share	5047.13	5307.22	5933.04	5897.81	5403.78
Tangible Book Value	69,571	72,531	82,062	81,588	77,162
Tangible Book Value Per Share	4490.00	4831.12	5465.90	5434.34	5139.54
Land	21,867	10,884	11,406	10,188	9,607
Buildings	24,595	25,046	30,181	12,824	15,655
Machinery	12,695	15,334	31,527	8,822	15,961
Construction In Progress	909.95	9,767	10,784	16,418	1,608

Source: S&P Global Market Intelligence. Standard template. Financial Sources.